Why a general reply is not a confirmed appointment
When you contact a hospital in China about cancer immunotherapy, the first response often comes from an international office, a general oncology mailbox or a coordination service. That reply can confirm that your message was received and that someone will look at your records. It does not confirm that a specific immunotherapy department has accepted your case, that a particular drug is available at that hospital, or that a treatment slot exists.
This distinction matters because immunotherapy is not one service. Whether it is appropriate depends on the cancer and individual assessment, as the National Cancer Institute explains. A hospital may offer immunotherapy for some tumour types and not others. It may have the drug you are asking about, or it may not. The department that reviews your file may be medical oncology, a tumour-specific centre, a haematology unit or a clinical trial office. Each of these has different intake routes and different people who can answer your question.
So the practical goal of early contact is not to collect a friendly reply. It is to get a named department, a named campus and a defined appointment type in writing, plus a clear statement of what that appointment can and cannot decide.
The three things to confirm before any travel planning
Ask the hospital to answer three questions in writing. First, which department will assess your case? Second, which campus or building will you attend? Third, what type of appointment is this: a records-based review, a specialist consultation, a treatment-planning visit or something else?
These three answers determine almost everything else. The department tells you who owns the clinical decision. The campus tells you where to go and which hospital address is correct, because large Chinese hospitals often operate several sites and an international office may be at a different location from the oncology clinic. The appointment type tells you what to prepare and what to expect. A records review may not require travel at all. A treatment-planning visit usually requires you to be present and may require tests that have not yet been done.
If any of these three answers is missing, you do not yet have a confirmed appointment. You have an enquiry in progress. That is normal at the start, but it should not be treated as a green light to book flights.
What to send so the department can actually answer
A department cannot confirm whether immunotherapy is appropriate for your diagnosis without enough clinical information. The minimum useful set is usually a pathology report that names the tumour type, any biomarker results your treating team has already used to discuss immunotherapy, a summary of previous treatments including what was given, when and how the cancer responded, current imaging reports and a short note of your main question.
You do not need to send a complete archive at first contact. A brief summary with the key reports is enough for the hospital to decide whether it can assess you. If something important is missing, the department should tell you what it needs rather than guess. Ask them to specify which documents are required for their review and whether translated copies are needed.
Keep your own question narrow. For example: "I have this tumour type, these biomarkers and this treatment history. Is immunotherapy appropriate for me, and if so, which approach would your department consider?" That is easier to answer than a general request for cancer treatment.
Questions that separate a real appointment from a holding reply
Once you have an initial response, ask these questions directly. Which department and which campus will see me? Is this appointment for a records review, a consultation or treatment planning? Which clinician or team will decide whether immunotherapy is appropriate? Does that decision require tests that must be done in China, or can existing records be used? If immunotherapy is considered appropriate, how would monitoring continue after I return home, and who would coordinate that with my local team?
The last question is often the one patients forget. Immunotherapy is not a single visit. It involves cycles, monitoring and management of side effects. Before travelling, you need to understand how the Chinese hospital would hand over monitoring to your local clinicians and what information they would provide. Ask whether they can give a written plan that your home team can follow.
If the hospital cannot answer these questions before you travel, that is useful information. It may mean the case is still being reviewed, or that the hospital is not the right route for your situation. Either way, you have learned something before spending money on travel.
What a confirmed appointment does and does not mean
A confirmed appointment means the hospital has agreed to see you or review your records on a specific date, in a specific department, at a specific campus. It does not mean the hospital has accepted you for immunotherapy. It does not mean the drug is available. It does not mean you are eligible for a clinical trial. Eligibility for trials, access to specific therapies and treatment decisions belong to the treating hospital and its clinicians after they assess your case.
This is why you should not treat an appointment confirmation as a treatment promise. The appointment is the start of the clinical assessment, not the end of it. The hospital may conclude that immunotherapy is not appropriate, that a different approach is better, or that more tests are needed. All of those are legitimate clinical outcomes.
If you are currently receiving treatment at home, do not interrupt it while waiting for an overseas reply. Ask your local team how to manage the period before any travel and whether any changes are safe. Urgent or worsening symptoms need local care, not an overseas enquiry.
A practical order of actions and the fallback
Start with a short summary and your main question. Ask for the department, campus and appointment type in writing. Send the key records the hospital requests. Then ask the clinical questions above. Only after you have clear answers should you plan travel.
If a step cannot be completed, do not force it. If the hospital cannot name a department, ask who else can. If it cannot confirm whether the drug is available, ask whether that will be decided at the appointment. If it cannot explain how monitoring would continue at home, ask for a written plan before committing to travel. If the reply remains general, consider whether a records-based opinion from a relevant specialist would help clarify your options before you travel. That is optional and not a prerequisite for every appointment.
ChinaSpecialistCare can help with non-clinical coordination, including requesting a specialist appointment, organising interpretation and helping you prepare records, as described on the cancer immunotherapy page. Clinical assessment, prescriptions and treatment decisions remain with the hospital and its licensed clinicians. An initial enquiry is free and does not require buying a proxy consultation.
The useful next step is to write down your three confirmation questions, send a brief summary with your main question, and wait for a written reply that names the department, the campus and the appointment type before you make any travel commitment.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.